Clinical trials in the era of personalized oncology.
Clinical trials in the era of personalized oncology.
复制标题
DOI:
10.3322/caac.20135
复制
发表时间:
2011-11
期刊:
影响因子:
--
通讯作者:
Schilsky RL
中科院分区:
文献类型:
--
作者:
Maitland ML;Schilsky RL
The rapid pace of discoveries in tumor biology, imaging technology, and human genetics hold promise for an era of personalized oncology care. The successful development of a handful of new targeted agents has generated much hope and hype about the delivery of safer and more effective new treatments for cancer. The design and conduct of clinical trials has not yet adjusted to a new era of personalized oncology and so we are more in transition to that era than in it. With the development of treatments for breast cancer as a model, we review the approaches to clinical trials and development of novel therapeutics in the prior era of population oncology, the current transitional era, and the future era of personalized oncology.
登录
查看更多内容
影响因子:
8.4
作者:
Eisenhauer, E. A.;Therasse, P.;Verweij, J.
通讯作者:
Verweij, J.
影响因子:
3.5
作者:
Catania, Chiara;De Pas, Tommaso;Nole, Franco
通讯作者:
Nole, Franco
影响因子:
45.3
作者:
Cobleigh, MA;Vogel, CL;Slamon, DJ
通讯作者:
Slamon, DJ
影响因子:
158.5
作者:
FISHER, B;REDMOND, C;SIDOROVICH, L
通讯作者:
SIDOROVICH, L
影响因子:
45.3
作者:
Agrawal, Manish;Grady, Christine;Emanuel, Ezekiel J.
通讯作者:
Emanuel, Ezekiel J.